Table 4.

Type of patient participation and evaluation in medication reviews – qualitative studies

Reference	Type of communication and by whom	Information given by patient to professional	Consultation by professional	Process or evaluation outcomes	Quality assessment
Sheridan et al. 45	Interview in pharmacy by pharmacist	Actual drug use Adherence Side effects Effectiveness Storage Use of equipment	Education	All but one patient were happy with the home visit Nearly all respondents felt that they had enough time to discuss relevant questions, and were responded adequately Patients did not report specific health gains directly from the MUR. However, knowledge and comfortable to discuss health or medication issues in the future with pharmacists were mentioned Pharmacists did believe that the MUR could have improved outcomes for patients The consultation lasted <30 min–1 h	Strong
Latif et al. 32	Home visits by pharmacist	Actual drug use Medication knowledge	Education	40–60% of the patients did not ask any questions during the MUR Little room for open questions, OTC discussion offered more scope for participation	Strong
Bissel et al. 52	Consultation with pharmacist	Actual drug use Compliance Lifestyle and social support	Not described	Majority expressed ambivalent views about the service, overall cautiously more positive than negative Helpful reassurance on illness and therapy Positive about the consultation with the pharmacist but reservations about them making recommendations. Many regard the doctor as the health professional in charge. Patient felt more knowledgeable on their medicines	Strong
Salter et al. 42	Home visits by pharmacist	Actual drug use	Advice, information, and instruction on medicines	Advice was often resisted or rejected and created interactional difficulties and awkward moments Almost no patient initiated requests for advice or information Calling on the higher authority of the doctor was prevalent Consultation time: mean 45 min	Strong
Petty et al. 40	Interview in clinic by clinical pharmacist	Actual drug use Medication issues	Explanation, not further defined	Some patients welcomed the opportunity to have questions answered Health care professionals must judge who needs more detailed information and who does not Not everybody accepted the advice given by the pharmacist	Strong
Chen et al. 18	Interview in pharmacy by clinical pharmacist	Effectiveness perception Side effects Adherence	Not described	Better understanding of patient's perspective, would facilitate concordance Consultation duration ranged from 15–90 min	Moderate
Nathan et al. 35	Interview in pharmacy by pharmacist	Actual drug use	Not described	Expression of satisfaction and gratitude Better understanding of medicines Re-assurement (for patients) that they were taking medicines correctly Learning things about medications that they not knew before	Strong

OTC, over the counter medicines; MUR, medication use review.